German Remedies, a part of the Zydus Group, has launched interferon beta-1b under the brand name "Betaferon" for the first time in India for the treatment of multiple sclerosis (MS), Cadila Healthcare Ltd announced here.
Betaferon is a subcutaneous injection and is the only Interferon efficacious even in the secondary progressive stage of multiple sclerosis. The product is being marketed in collaboration with Schering AG, Germany.
J C Jani, executive director of Zydus Cadila and Head of German Remedies stated, " Effective and early treatment of MS are important as medications can help slow down the development of MS disability. The launch of Betaferon is yet another step towards a strong collaborative enterprise between Zydus and Schering AG in offering innovative healthcare therapies in the fields of Female Healthcare, Cancer therapy and Radiology."